These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16467033)

  • 1. Progress and regression within primary Sjögren's syndrome.
    Manthorpe R; Bredberg A; Henriksson G; Larsson A
    Scand J Rheumatol; 2006; 35(1):1-6. PubMed ID: 16467033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
    Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
    Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Sjögren's syndrome: new clinical and therapeutic concepts.
    Ramos-Casals M; Tzioufas AG; Font J
    Ann Rheum Dis; 2005 Mar; 64(3):347-54. PubMed ID: 15498797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary manifestations of primary Sjögren's syndrome.
    Sarkar PK; Patel N; Furie RA; Talwar A
    Indian J Chest Dis Allied Sci; 2009; 51(2):93-101. PubMed ID: 19445445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapy of Sjogren's syndrome: a review.
    Coaccioli S; Giuliani M; Puxeddu A
    Clin Ter; 2007; 158(5):453-6. PubMed ID: 18062353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab therapy in primary Sjögren's syndrome.
    Alcântara C; Gomes MJ; Ferreira C
    Ann N Y Acad Sci; 2009 Sep; 1173():701-5. PubMed ID: 19758218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarials in Sjögren's syndrome--the Greek experience.
    Manoussakis MN; Moutsopoulos HM
    Lupus; 1996 Jun; 5 Suppl 1():S28-30. PubMed ID: 8803907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome.
    Szodoray P; Jonsson R
    Scand J Immunol; 2005 Nov; 62(5):421-8. PubMed ID: 16305638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to the treatment of Sjögren's syndrome.
    Fox RI; Michelson P
    J Rheumatol Suppl; 2000 Dec; 61():15-21. PubMed ID: 11128699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy.
    Fox PC
    Ann N Y Acad Sci; 2007 Mar; 1098():15-21. PubMed ID: 17332090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues related to clinical trials of oral and biologic disease-modifying agents for Sjögren's syndrome.
    Carsons SE
    Rheum Dis Clin North Am; 2008 Nov; 34(4):1011-23, x. PubMed ID: 18984419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD20 treatment in primary Sjögren's syndrome.
    Isaksen K; Jonsson R; Omdal R
    Scand J Immunol; 2008 Dec; 68(6):554-64. PubMed ID: 19000095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
    Tzioufas AG; Voulgarelis M
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired factor VIII inhibitor in Sjögren's syndrome.
    Vintimilla M; Joseph A; Ranganathan P
    Arthritis Care Res (Hoboken); 2010 Jul; 62(7):1047-50. PubMed ID: 20589701
    [No Abstract]   [Full Text] [Related]  

  • 16. Will targeting B cells be the answer for Sjögren's syndrome?
    Looney RJ
    Arthritis Rheum; 2007 May; 56(5):1371-7. PubMed ID: 17469093
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.
    Ahmadi-Simab K; Lamprecht P; Nölle B; Ai M; Gross WL
    Ann Rheum Dis; 2005 Jul; 64(7):1087-8. PubMed ID: 15958765
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab and primary Sjogren's syndrome: comment on the article by Mariette et al.
    Fresko I; Seyahi E; Yurdakul S
    Arthritis Rheum; 2004 Dec; 50(12):4077; author reply 4077-8. PubMed ID: 15593208
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab in primary Sjögren's syndrome: one-year followup.
    Steinfeld SD; Demols P; Appelboom T
    Arthritis Rheum; 2002 Dec; 46(12):3301-3. PubMed ID: 12483735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
    Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
    Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.